Galectins in Atherosclerotic Disease

Trends in Cardiovascular Medicine

Volumn 19, Issue 5, 2009, Pages 164-169

  Al Ansari, Sali ^a   Zeebregts, Clark J ^a   Slart, Riemer H J A ^a   Peppelenbosch, Maikel ^a   Tio, René A ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CARBOHYDRATE BINDING PROTEIN; CYTOKINE; GALECTIN; HORMONE;

ADAPTATION; ATHEROSCLEROSIS; CARDIOVASCULAR DISEASE; CELL FUNCTION; CELL INTERACTION; HEART FAILURE; HEART INFARCTION; HUMAN; HUMORAL IMMUNITY; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; RECEPTOR BINDING; REVIEW; SIGNAL TRANSDUCTION; STROKE;

APOPTOSIS; ATHEROSCLEROSIS; CARBOHYDRATE METABOLISM; GALECTINS; HUMANS; SIGNAL TRANSDUCTION;

EID: 71249110671     PISSN: 10501738     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tcm.2009.10.001     Document Type: Review

References (55)

1. Arar C., Gaudin J.C., Capron L., and Legrand A. Galectin-3 gene (LGALS3) expression in experimental atherosclerosis and cultured smooth muscle cells. FEBS Lett 430 (1998) 307-311
2. Asselbergs F.W., Pai J.K., Rexrode K.M., et al. Effects of lymphotoxin-alpha gene and galectin-2 gene polymorphisms on inflammatory biomarkers, cellular adhesion molecules and risk of coronary heart disease. Clin Sci (Lond) 112 (2007) 291-298
3. Bernerd F., Sarasin A., and Magnaldo T. Galectin-7 overexpression is associated with the apoptotic process in UVB-induced sunburn keratinocytes. Proc Natl Acad SciU S A 96 (1999) 11329-11334
4. Califice S., Castronovo V., Bracke M., and van den Brule F. Dual activities of galectin-3 in human prostate cancer: tumor suppression of nuclear galectin-3 vs tumor promotion of cytoplasmic galectin-3. Oncogene 23 (2004) 7527-7536
5. Cartier R., Brunette I., Hashimoto K., et al. Angiogenic factor: a possible mechanism for neovascularization produced by omental pedicles. J Thorac Cardiovasc Surg 99 (1990) 264-268
6. Chellan B., Narayani J., and Appukuttan P.S. Galectin-1, an endogenous lectin produced by arterial cells, binds lipoprotein(a) [Lp(a)] in situ: relevance to atherogenesis. Exp Mol Pathol 83 (2007) 399-404
7. Cooper D.N., Boulianne R.P., Charlton S., et al. Fungal galectins, sequence and specificity of two isolectins from Coprinus cinereus. J Biol Chem 272 (1997) 1514-1521
8. Dumic J., Dabelic S., and Flogel M. Galectin-3: an open-ended story. Biochim Biophys Acta 1760 (2006) 616-635
9. Fukushi J., Makagiansar I.T., and Stallcup W.B. NG2 proteoglycan promotes endothelial cell motility and angiogenesis via engagement of galectin-3 and alpha3beta1 integrin. Mol Biol Cell 15 (2004) 3580-3590
10. Haudek K.C., Spronk K.J., Voss P.G., et al. Dynamics of galectin-3 in the nucleus and cytoplasm. Biochim Biophys Acta (2009)
11. Hinohara, et al. J Hum Genet (2009)
12. Houtkamp M.A., de Boer O.J., van der Loos C.M., et al. Adventitial infiltrates associated with advanced atherosclerotic plaques: structural organization suggests generation of local humoral immune responses. J Pathol 193 (2001) 263-269
13. Hughes R.C. Secretion of the galectin family of mammalian carbohydrate-binding proteins. Biochim Biophys Acta 1473 (1999) 172-185
14. Iacobini C., Menini S., Ricci C., et al. Accelerated lipid-induced atherogenesis in galectin-3-deficient mice: role of lipoxidation via receptor-mediated mechanisms. Arterioscler Thromb Vasc Biol 29 (2009) 831-836
15. Inoue M., Itoh H., Ueda M., et al. Vascular endothelial growth factor (VEGF) expression in human coronary atherosclerotic lesions: possible pathophysiological significance of VEGF in progression of atherosclerosis. Circulation 98 (1998) 2108-2116
16. Kadrofske M.M., Openo K.P., and Wang J.L. The human LGALS3 (galectin-3) gene: determination of the gene structure and functional characterization of the promoter. Arch Biochem Biophys 349 (1998) 7-20
17. Karlsson A., Follin P., Leffler H., and Dahlgren C. Galectin-3 activates the NADPH-oxidase in exudated but not peripheral blood neutrophils. Blood 91 (1998) 3430-3438
18. Kim K., Mayer E.P., and Nachtigal M. Galectin-3 expression in macrophages is signaled by Ras/MAP kinase pathway and up-regulated by modified lipoproteins. Biochim Biophys Acta 1641 (2003) 13-23
19. Kimura A., Takahashi M., Choi B.Y., et al. Lack of association between LTA and LGALS2 polymorphisms and myocardial infarction in Japanese and Korean populations. Tissue Antigens 69 (2007) 265-269
20. Lange F., Brandt B., Tiedge M., et al. Galectin-1 induced activation of the mitochondrial apoptotic pathway: evidence for a connection between death-receptor and mitochondrial pathways in human Jurkat T lymphocytes. Histochem Cell Biol (2009)
21. Le Q.T., Shi G., Cao H., et al. Galectin-1: a link between tumor hypoxia and tumor immune privilege. J Clin Oncol 23 (2005) 8932-8941
22. Leek R.D., Lewis C.E., Whitehouse R., et al. Association of macrophage infiltration with angiogenesis and prognosis in invasive breast carcinoma. Cancer Res 56 (1996) 4625-4629
23. Li W., Xu J., Wang X., et al. Lack of association between lymphotoxin-alpha, galectin-2 polymorphisms and coronary artery disease: a meta-analysis. Atherosclerosis (2009)
24. Lin H.M., Pestell R.G., Raz A., and Kim H.R. Galectin-3 enhances cyclin D(1) promoter activity through SP1 and a cAMP-responsive element in human breast epithelial cells. Oncogene 21 (2002) 8001-8010
25. Liu F.T., Hsu D.K., Zuberi R.I., et al. Expression and function of galectin-3, a beta-galactoside-binding lectin, in human monocytes and macrophages. Am J Pathol 147 (1995) 1016-1028
26. Liu F.T., Patterson R.J., and Wang J.L. Intracellular functions of galectins. Biochim Biophys Acta 1572 (2002) 263-273
27. MacKinnon A.C., Farnworth S.L., Hodkinson P.S., et al. Regulation of alternative macrophage activation by galectin-3. J Immunol 180 (2008) 2650-2658
28. Mangino M., Braund P., Singh R., et al. LGALS2 functional variant rs7291467 is not associated with susceptibility to myocardial infarction in Caucasians. Atherosclerosis 194 (2007) 112-115
29. Mey A., Leffler H., Hmama Z., et al. The animal lectin galectin-3 interacts with bacterial lipopolysaccharides via two independent sites. J Immunol 156 (1996) 1572-1577
30. Moiseeva E.P., Javed Q., Spring E.L., and de Bono D.P. Galectin 1 is involved in vascular smooth muscle cell proliferation. Cardiovasc Res 45 (2000) 493-502
31. Moiseeva E.P., Williams B., Goodall A.H., and Samani N.J. Galectin-1 interacts with beta-1 subunit of integrin. Biochem Biophys Res Commun 310 (2003) 1010-1016
32. Moos M.P., John N., Grabner R., et al. The lamina adventitia is the major site of immune cell accumulation in standard chow-fed apolipoprotein E-deficient mice. Arterioscler Thromb Vasc Biol 25 (2005) 2386-2391
33. Nachtigal M., Al Assaad Z., Mayer E.P., et al. Gene expression in macrophage foam cells of carrageenan-induced granulomas in hypercholesterolemic rabbits. FASEB J 8 (1994) A393
34. Nachtigal M., Al Assaad Z., Mayer E.P., et al. Galectin-3 expression in human atherosclerotic lesions. Am J Pathol 152 (1998) 1199-1208
35. Nachtigal M., Ghaffar A., and Mayer E.P. Galectin-3 gene inactivation reduces atherosclerotic lesions and adventitial inflammation in ApoE-deficient mice. Am J Pathol 172 (2008) 247-255
36. Nangia-Makker P., Honjo Y., Sarvis R., et al. Galectin-3 induces endothelial cell morphogenesis and angiogenesis. Am J Pathol 156 (2000) 899-909
37. Ochieng J., Furtak V., and Lukyanov P. Extracellular functions of galectin-3. Glycoconj J 19 (2004) 527-535
38. Osterud B., and Bjorklid E. Role of monocytes in atherogenesis. Physiol Rev 83 (2003) 1069-1112
39. Ozaki K., Inoue K., Sato H., et al. Functional variation in LGALS2 confers risk of myocardial infarction and regulates lymphotoxin-alpha secretion in vitro. Nature 429 (2004) 72-75
40. Ozaki K., Sato H., Inoue K., et al. SNPs in BRAP associated with risk of myocardial infarction in Asian populations. Nat Genet 41 (2009) 329-333
41. Perillo N.L., Marcus M.E., and Baum L.G. Galectins: versatile modulators of cell adhesion, cell proliferation, and cell death. J Mol Med 76 (1998) 402-412
42. Perillo N.L., Pace K.E., Seilhamer J.J., and Baum L.G. Apoptosis of T cells mediated by galectin-1. Nature 378 (1995) 736-739
43. Perillo N.L., Uittenbogaart C.H., Nguyen J.T., and Baum L.G. Galectin-1, an endogenous lectin produced by thymic epithelial cells, induces apoptosis of human thymocytes. J Exp Med 185 (1997) 1851-1858
44. Polverini P.J. How the extracellular matrix and macrophages contribute to angiogenesis-dependent diseases. Eur J Cancer 32A (1996) 2430-2437
45. Rong J.X., Shapiro M., Trogan E., and Fisher E.A. Transdifferentiation of mouse aortic smooth muscle cells to a macrophage-like state after cholesterol loading. Proc Natl Acad Sci U S A 100 (2003) 13531-13536
46. Sano H., Hsu D.K., Yu L., et al. Human galectin-3 is a novel chemoattractant for monocytes and macrophages. J Immunol 165 (2000) 2156-2164
47. Silverman K.J., Lund D.P., Zetter B.R., et al. Angiogenic activity of adipose tissue. Biochem Biophys Res Commun 153 (1988) 347-352
48. Stowell S.R., Dias-Baruffi M., Penttila L., et al. Human galectin-1 recognition of poly-N-acetyllactosamine and chimeric polysaccharides. Glycobiology 14 (2004) 157-167
49. Ueda S., Kuwabara I., and Liu F.T. Suppression of tumor growth by galectin-7 gene transfer. Cancer Res 64 (2004) 5672-5676
50. van Kimmenade R.R., Januzzi Jr. J.L., Ellinor P.T., et al. Utility of amino-terminal pro-brain natriuretic peptide, galectin-3, and apelin for the evaluation of patients with acute heart failure. J Am Coll Cardiol 48 (2006) 1217-1224
51. Vlassara H., Li Y.M., Imani F., et al. Identification of galectin-3 as a high-affinity binding protein for advanced glycation end products (AGE): a new member of the AGE-receptor complex. Mol Med 1 (1995) 634-646
52. Wada J., Ota K., Kumar A., et al. Developmental regulation, expression, and apoptotic potential of galectin-9, a beta-galactoside binding lectin. J Clin Invest 99 (1997) 2452-2461
53. Yang R.Y., Hsu D.K., and Liu F.T. Expression of galectin-3 modulates T-cell growth and apoptosis. Proc Natl Acad Sci U S A 93 (1996) 6737-6742
54. Zanetta J.P., Badache A., Maschke S., et al. Carbohydrates and soluble lectins in the regulation of cell adhesion and proliferation. Histol Histopathol 9 (1994) 385-412
55. Zhu W., Sano H., Nagai R., et al. The role of galectin-3 in endocytosis of advanced glycation end products and modified low density lipoproteins. Biochem Biophys Res Commun 280 (2001) 1183-1188